These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24634940)

  • 1. Telomere length and telomerase reverse transcriptase mRNA expression in patients with hepatitis C.
    Biron-Shental T; Amiel A; Anchidin R; Sharony R; Hadary R; Kitay-Cohen Y
    Hepatogastroenterology; 2013 Oct; 60(127):1713-6. PubMed ID: 24634940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
    Satra M; Dalekos GN; Kollia P; Vamvakopoulos N; Tsezou A
    J Viral Hepat; 2005 Sep; 12(5):488-93. PubMed ID: 16108763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length in Hepatitis C.
    Kitay-Cohen Y; Goldberg-Bittman L; Hadary R; Fejgin MD; Amiel A
    Cancer Genet Cytogenet; 2008 Nov; 187(1):34-8. PubMed ID: 18992639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Biron-Shental T; Konikoff FM; Amiel A; Kitay-Cohen Y
    Cytogenet Genome Res; 2016; 150(2):93-99. PubMed ID: 28006764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.
    Hartmann U; Brümmendorf TH; Balabanov S; Thiede C; Illme T; Schaich M
    Haematologica; 2005 Mar; 90(3):307-16. PubMed ID: 15749662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
    Gertler R; Doll D; Maak M; Feith M; Rosenberg R
    Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
    Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere aggregates in hepatitis C patients.
    Amiel A; Fejgin MD; Goldberg-Bittman L; Sharoni R; Hadary R; Kitay-Cohen Y
    Cancer Invest; 2009 Jul; 27(6):650-4. PubMed ID: 19452298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Invernizzi P; Bernuzzi F; Lleo A; Pozzoli V; Bignotto M; Zermiani P; Crosignani A; Battezzati PM; Zuin M; Podda M; Raggi C
    Dig Liver Dis; 2014 Apr; 46(4):363-8. PubMed ID: 24378524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors.
    Nishio Y; Nakanishi K; Ozeki Y; Jiang SX; Kameya T; Hebisawa A; Mukai M; Travis WD; Franks TJ; Kawai T
    Jpn J Clin Oncol; 2007 Jan; 37(1):16-22. PubMed ID: 17060405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
    Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
    J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
    Gonzalo V; Petit A; Castellví-Bel S; Pellisé M; Muñoz J; Piñol C; Rodríguez-Moranta F; Clofent J; Balaguer F; Giráldez MD; Ocaña T; Serradesanferm A; Grau J; Reñé JM; Panés J; Castells A
    Gastroenterol Hepatol; 2010 Apr; 33(4):288-96. PubMed ID: 20334955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
    Getliffe KM; Al Dulaimi D; Martin-Ruiz C; Holder RL; von Zglinicki T; Morris A; Nwokolo CU
    Aliment Pharmacol Ther; 2005 Jan; 21(2):121-31. PubMed ID: 15679761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.
    Hájek M; Cvilink V; Votruba I; Holý A; Mertlíková-Kaiserová H
    Eur J Pharmacol; 2010 Sep; 643(1):6-12. PubMed ID: 20599933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis.
    Demerdash HM; Elyamany AS; Arida E
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):494-498. PubMed ID: 30444746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.